Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Eman Selima"'
Autor:
Yasmin El Zouka, Eman Sheta, Mona Abdelrazek Salama, Eman Selima, Rowaida Refaat, Sherihan Salaheldin Abdelhamid Ibrahim
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-19 (2024)
Abstract Atherosclerosis (AS) is a major cause of cardiovascular diseases that may lead to mortality. This study aimed to evaluate the therapeutic potential of tetrandrine in high cholesterol diet (HCD)-induced atherosclerosis, in rats, via modulatio
Externí odkaz:
https://doaj.org/article/4a391b7a9a8d43e5aa86ccb6154de4e9
Publikováno v:
Life Sciences. 260:118261
Aims Rheumatoid arthritis is an autoimmune systemic disorder causing pain, swelling, stiffness, and disability in various joints. This work was designed to evaluate the effect of sitagliptin and tofacitinib on Janus kinase (JAK)/signaling transducer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaae1bfd0e9d3edb7ab2fd351e9b6254
https://doi.org/10.1016/j.lfs.2020.118261
https://doi.org/10.1016/j.lfs.2020.118261
Publikováno v:
European Journal of Pharmacology. 720:1-6
The aim of this study was to evaluate the effects of chronic nicotine administration on bone mineral homeostasis in rapidly growing young rats in comparison to effects in adult male rats. Two doses of nicotine (3 and 4.5mg/kg/day, as nicotine hydroge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bafd3742d018a2699f0d29fea0e74393
https://doi.org/10.1016/j.ejphar.2013.10.061
https://doi.org/10.1016/j.ejphar.2013.10.061
Publikováno v:
European Journal of Pharmacology. 714:448-455
Increasing evidence has established causative links between obesity, chronic inflammation and insulin resistance; the core pathophysiological feature in type 2 diabetes mellitus. This study was designed to examine whether the combination of L-cystein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::879dfdf47a93794425a84d78e9916ab5
https://doi.org/10.1016/j.ejphar.2013.07.002
https://doi.org/10.1016/j.ejphar.2013.07.002
Publikováno v:
European journal of pharmacology. 723
No effective chemopreventive agent has been approved against hepatocellular carcinoma (HCC) to date. Since HCC is one of the hypervascular solid tumors, blocking angiogenesis represents an intriguing approach to HCC chemoprevention. The aim of the cu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fc0daaa5eecbbfe68d4a402b12e9c59
https://pubmed.ncbi.nlm.nih.gov/24291100
https://pubmed.ncbi.nlm.nih.gov/24291100